Clinical Chemistry

Novel Biomarker Identifies Early Clinical CV Disease

Coronary artery disease (CAD) is one of the leading causes of morbidity and mortality worldwide, and the economic, social, and costs associated with treating CAD are very high. The severity of coronary artery lesions has been proven to be associated with the risk of future cardiovascular events.

Latest Clinical Chemistry News